CD8A and head and neck squamous cell carcinoma: Since a shift in pro-apoptotic and anti-apoptotic proteins, as well as molecular defects in circulating CD8+ T cells in the blood of HNSCC patients, have been observed [36], molecular characterization of effector cell subgroups could be performed in the SCC VII/C3H/HeN mouse model in a more controlled environment.